Controlled‐Disorder Asymmetrical Donors Enable Efficient All‐Small‐Molecule Solar Cells with Excellent Solution‐Processability
Angewandte Chemie International Edition · 09.01.2026 · 65 (2)
DOI: 10.1002/anie.202519713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 16.11.2025. Verfasst von Lin-Yong Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Institute for Advanced Studies, Wuhan University, Wuhan, 430072, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: the National Natural Science Foundation of China (NSFC), Hubei Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
All‐small‐molecule organic solar cells (all‐SMOSCs) are promising candidates for next‐generation photovoltaics owing to their well‐defined molecular structures and excellent batch‐to‐batch reproducibility, yet their efficiency is limited by morphology control and processability. Here, we report three asymmetric small molecule donors—MPhS‐HF, MPhS‐OP, and MPhS‐PF—engineered with distinct side‐chain functionalities to systematically investigate the interplay between molecular design, solution‐state interactions, crystallization kinetics, and blend morphology. Among them, MPhS‐OP demonstrates delayed crystallization and favorable miscibility with the non‐fullerene acceptor L8‐BO, enabling the formation of finely interpenetrating network morphologies that facilitate efficient exciton dissociation, balanced charge transport, and suppressed recombination losses. As a result, binary MPhS‐OP:L8‐BO devices achieve a record power conversion efficiency of 18.12% under conventional spin‐coating, along with exceptional processing tolerance, maintaining > 16.4% efficiency in thick‐film, high‐speed blade‐coated, green solvent‐processed, and large‐area devices. In situ spectroscopy and thermodynamic modeling reveal that the superior performance arises from the distinct film‐formation dynamics of MPhS‐OP, which delays donor precipitation relative to L8‐BO, suppressing premature phase segregation and ensuring reproducible nano‐interpenetrating morphologies across processing conditions. This work establishes asymmetric small molecule donor design as a powerful strategy to couple molecular packing control with solution processability, offering a viable route toward scalable and high‐performance all‐SMOSCs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Institute for Advanced Studies, Wuhan University, Wuhan, 430072, China.
- Key Laboratory of Optoelectronic Chemical Materials and Devices (Ministry of Education), School of Optoelectronic Materials & Technology, Jianghan University, Wuhan, 430056, China.
Förderung
- the National Natural Science Foundation of China (NSFC)
- Hubei Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Xu, L. Y., Gao, Y., Sun, R., Xing, Z., Xiao, B., Yang, X., Shao, Y., Chang, B., Wu, X., Xiao, B., Zhang, M., & Min, J. (2026). Controlled‐Disorder Asymmetrical Donors Enable Efficient All‐Small‐Molecule Solar Cells with Excellent Solution‐Processability. Angewandte Chemie International Edition, 65(2). https://doi.org/10.1002/anie.202519713
Vancouver
Xu LY, Gao Y, Sun R, Xing Z, Xiao B, Yang X, et al. Controlled‐Disorder Asymmetrical Donors Enable Efficient All‐Small‐Molecule Solar Cells with Excellent Solution‐Processability. Angewandte Chemie International Edition. 2026;65(2). doi:10.1002/anie.202519713
BibTeX
@article{Xu2026,
author = {Xu, Lin-Yong and Gao, Yuan and Sun, Rui and Xing, Zicheng and Xiao, Bo and Yang, Xinrong and Shao, Yiming and Chang, Bowen and Wu, Xiaohei and Xiao, Biao and Zhang, Meimei and Min, Jie},
title = {Controlled‐Disorder Asymmetrical Donors Enable Efficient All‐Small‐Molecule Solar Cells with Excellent Solution‐Processability},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {2},
doi = {10.1002/anie.202519713}
}
EUVIMED